Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chunkang Xuezhi Capsule in Primary Hyperlipidemia
CTR20171217Phase 2Active
- Sponsor
- Aoteqi Mongolian Medicine
- Start
- Oct 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Chunkang Xuezhi Capsule in familial hyperlipidemia, sponsored by Aoteqi Mongolian Medicine. Started Oct 2017; status: active.
02
Drugs
Chunkang Xuezhi Capsule
03
Conditions
familial hyperlipidemia
Beyond the preview
Go deeper on CTR20171217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171217.